<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1160"/><api:result><api:object category="publication" id="1160" last-affected-when="2024-04-14T19:13:37.32+01:00" last-modified-when="2024-04-14T19:13:37.32+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1160" created-when="2010-05-17T13:47:32.63+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>false</api:ever-approved><api:reporting-date-1>2000-08-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518196" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1530/eje.0.1430179" last-modified-when="2023-02-25T23:17:18.883+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;OBJECTIVE: In patients with acute myocardial infarction (AMI), low triiodothyronine (T(3)) levels with normal or subnormal levels of thyrotropin (TSH), the euthyroid sick syndrome (ESS), have been reported, however, the mechanism of altered thyroid hormone metabolism is unknown. Recent reports have shown that interleukin-6 (IL-6) plays a key role in the pathogenesis of AMI and ESS. This preliminary study investigates the relationship between thyroid states and plasma levels of IL-6, the soluble IL-6 receptor (sIL-6R), and the soluble transducing 130kDa glycoprotein (sgp130) in AMI. DESIGN AND METHODS: We measured the concentration of TSH, free T(3) (FT(3)), free thyroxine (FT(4)), IL-6, sIL-6R and sgp130 in plasma from 24 patients with AMI and 20 normal controls. RESULTS: All 24 AMI patients showed significantly lower concentrations of FT(3) with normal or subnormal levels of TSH, and higher concentrations of IL-6 and sIL-6R than controls. IL-6 level was correlated with creatine phosphokinase (CPK) and FT(3) levels but not with FT(4 )or TSH levels in patients with AMI. The time course of IL-6 and FT(3 )concentration seemed to be closely linked. sIL-6R level was correlated with CPK and sgp130 levels, but not with FT(3), FT(4) or TSH levels. FT(4 )level was correlated with sgp130 level. CONCLUSION: Patients with AMI develop ESS through activation of IL-6 and its receptor system.&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Kimura</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kanda</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kotajima</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kuwabara</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fukumura</api:last-name><api:initials>Y</api:initials><api:first-names>Y</api:first-names><api:separate-first-names><api:first-name>Y</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kobayashi</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1530/eje.0.1430179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1530/eje.0.1430179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1530/eje.0.1430179"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1479-683X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0804-4643</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Endocrinology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>179</api:begin-page><api:end-page>184</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Oxford University Press (OUP)</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1530/eje.0.1430179</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>14</api:day><api:month>2</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction</api:text></api:field></api:native></api:record><api:record format="native" id="1160" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10913935" last-modified-when="2020-04-29T00:34:33.627+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>OBJECTIVE: In patients with acute myocardial infarction (AMI), low triiodothyronine (T(3)) levels with normal or subnormal levels of thyrotropin (TSH), the euthyroid sick syndrome (ESS), have been reported, however, the mechanism of altered thyroid hormone metabolism is unknown. Recent reports have shown that interleukin-6 (IL-6) plays a key role in the pathogenesis of AMI and ESS. This preliminary study investigates the relationship between thyroid states and plasma levels of IL-6, the soluble IL-6 receptor (sIL-6R), and the soluble transducing 130kDa glycoprotein (sgp130) in AMI. DESIGN AND METHODS: We measured the concentration of TSH, free T(3) (FT(3)), free thyroxine (FT(4)), IL-6, sIL-6R and sgp130 in plasma from 24 patients with AMI and 20 normal controls. RESULTS: All 24 AMI patients showed significantly lower concentrations of FT(3) with normal or subnormal levels of TSH, and higher concentrations of IL-6 and sIL-6R than controls. IL-6 level was correlated with creatine phosphokinase (CPK) and FT(3) levels but not with FT(4 )or TSH levels in patients with AMI. The time course of IL-6 and FT(3 )concentration seemed to be closely linked. sIL-6R level was correlated with CPK and sgp130 levels, but not with FT(3), FT(4) or TSH levels. FT(4 )level was correlated with sgp130 level. CONCLUSION: Patients with AMI develop ESS through activation of IL-6 and its receptor system.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Kimura</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="JP"><api:line type="full">Department of General Medicine and Clinical Laboratory Center, Gunma University School of Medicine, Japan.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Kanda</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kotajima</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kuwabara</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fukumura</api:last-name><api:initials>Y</api:initials><api:first-names>Y</api:first-names><api:separate-first-names><api:first-name>Y</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kobayashi</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10913935</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1530/eje.0.1430179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1530/eje.0.1430179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1530/eje.0.1430179"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0804-4643</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eur J Endocrinol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Creatine Kinase</api:keyword><api:keyword scheme="mesh">Euthyroid Sick Syndromes</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-6</api:keyword><api:keyword scheme="mesh">Kinetics</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Myocardial Infarction</api:keyword><api:keyword scheme="mesh">Receptors, Interleukin-6</api:keyword><api:keyword scheme="mesh">Thyrotropin</api:keyword><api:keyword scheme="mesh">Thyroxine</api:keyword><api:keyword scheme="mesh">Triiodothyronine</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>179</api:begin-page><api:end-page>184</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>1430179</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>24</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>143</api:text></api:field></api:native></api:record><api:record format="native" id="882280" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10913935" last-modified-when="2023-01-31T17:47:26.53+00:00"><api:citation-count>35</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Objective&lt;/h4&gt;In patients with acute myocardial infarction (AMI), low triiodothyronine (T(3)) levels with normal or subnormal levels of thyrotropin (TSH), the euthyroid sick syndrome (ESS), have been reported, however, the mechanism of altered thyroid hormone metabolism is unknown. Recent reports have shown that interleukin-6 (IL-6) plays a key role in the pathogenesis of AMI and ESS. This preliminary study investigates the relationship between thyroid states and plasma levels of IL-6, the soluble IL-6 receptor (sIL-6R), and the soluble transducing 130kDa glycoprotein (sgp130) in AMI.&lt;h4&gt;Design and methods&lt;/h4&gt;We measured the concentration of TSH, free T(3) (FT(3)), free thyroxine (FT(4)), IL-6, sIL-6R and sgp130 in plasma from 24 patients with AMI and 20 normal controls.&lt;h4&gt;Results&lt;/h4&gt;All 24 AMI patients showed significantly lower concentrations of FT(3) with normal or subnormal levels of TSH, and higher concentrations of IL-6 and sIL-6R than controls. IL-6 level was correlated with creatine phosphokinase (CPK) and FT(3) levels but not with FT(4 )or TSH levels in patients with AMI. The time course of IL-6 and FT(3 )concentration seemed to be closely linked. sIL-6R level was correlated with CPK and sgp130 levels, but not with FT(3), FT(4) or TSH levels. FT(4 )level was correlated with sgp130 level.&lt;h4&gt;Conclusion&lt;/h4&gt;Patients with AMI develop ESS through activation of IL-6 and its receptor system.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="JP"><api:line type="full">Department of General Medicine and Clinical Laboratory Center, Gunma University School of Medicine, Japan.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Kimura</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kanda</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kotajima</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kuwabara</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fukumura</api:last-name><api:initials>Y</api:initials><api:first-names>Y</api:first-names><api:separate-first-names><api:first-name>Y</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kobayashi</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1530/eje.0.1430179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1530/eje.0.1430179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1530/eje.0.1430179"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1479-683X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10913935</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0804-4643</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European journal of endocrinology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Myocardial Infarction</api:keyword><api:keyword scheme="mesh">Euthyroid Sick Syndromes</api:keyword><api:keyword scheme="mesh">Thyrotropin</api:keyword><api:keyword scheme="mesh">Triiodothyronine</api:keyword><api:keyword scheme="mesh">Thyroxine</api:keyword><api:keyword scheme="mesh">Creatine Kinase</api:keyword><api:keyword scheme="mesh">Receptors, Interleukin-6</api:keyword><api:keyword scheme="mesh">Interleukin-6</api:keyword><api:keyword scheme="mesh">Kinetics</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>179</api:begin-page><api:end-page>184</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>7</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>143</api:text></api:field></api:native></api:record><api:record format="native" id="3098851" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1008007607" last-modified-when="2024-04-14T19:13:37.33+01:00"><api:citation-count>48</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Kimura</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="JP"><api:line type="organisation">Gunma University</api:line><api:line type="city">Maebashi</api:line><api:line type="country">Japan</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01213766461.77</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kanda</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01337244600.71</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kotajima</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0603144210.92</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kuwabara</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01206303226.68</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fukumura</api:last-name><api:initials>Y</api:initials><api:first-names>Y</api:first-names><api:separate-first-names><api:first-name>Y</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01126232272.77</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kobayashi</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.07566273602.20</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1530/eje.0.1430179</api:text><api:links><api:link type="doi" href="http://doi.org/10.1530/eje.0.1430179"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1530/eje.0.1430179"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10913935</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>7.9</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0804-4643</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Endocrinology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Heart Disease</api:keyword><api:keyword scheme="rcdc">Cardiovascular</api:keyword><api:keyword scheme="rcdc">Heart Disease - Coronary Heart Disease</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Creatine Kinase</api:keyword><api:keyword scheme="mesh">Euthyroid Sick Syndromes</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-6</api:keyword><api:keyword scheme="mesh">Kinetics</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Myocardial Infarction</api:keyword><api:keyword scheme="mesh">Receptors, Interleukin-6</api:keyword><api:keyword scheme="mesh">Thyrotropin</api:keyword><api:keyword scheme="mesh">Thyroxine</api:keyword><api:keyword scheme="mesh">Triiodothyronine</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>179</api:begin-page><api:end-page>184</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Oxford University Press (OUP)</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>1.06</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>143</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Creatine Kinase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Euthyroid Sick Syndromes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Kinetics</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Myocardial Infarction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Receptors, Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Thyrotropin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Thyroxine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Triiodothyronine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Myocardial Infarction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Euthyroid Sick Syndromes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Thyrotropin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Triiodothyronine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Thyroxine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Creatine Kinase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Receptors, Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Kinetics</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Heart Disease</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cardiovascular</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Heart Disease - Coronary Heart Disease</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Creatine Kinase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Euthyroid Sick Syndromes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Kinetics</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Myocardial Infarction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Receptors, Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Thyrotropin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Thyroxine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Triiodothyronine</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1114 Paediatrics and Reproductive Medicine</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Endocrinology &amp; Metabolism</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3215 Reproductive medicine</api:keyword></api:keywords></api:all-labels><api:journal issn="0804-4643" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973862" title="European Journal of Endocrinology (EJE)"><api:records><api:record source-name="summary"><api:title>European Journal of Endocrinology (EJE)</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1160/relationships"/></api:object></api:result></api:response>